Bovilis Nasalgen-C

Authorised

This medicine is authorised for use in the European Union

bovine coronavirus, strain CA25, live

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

Product details

• Name of medicine:
  Bovilis Nasalgen-C
• Active substance:
  bovine coronavirus, strain CA25, live
• International non-proprietary name (INN) or common name:
  bovine coronavirus, strain CA25, live

Pharmacotherapeutic group

• Immunologicals for bovidae
• Live viral vaccines
• bovine coronavirus

Authorisation details

• EMA product number:
  EMEA/V/C/005906

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Bovilis Nasalgen-C

AdoptedReference Number: EMA/CVMP/42050/2023